Anabasis S.R.L.
Records under this name other than patents Anabasis S.R.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Anabasis S.R.L.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,345,749 | Method of treating intraoccular tissue pathologies with nerve growth factor Formerly held Term ended Ended no later than Jan 21, 2020 · USPTO record | Term ended | Ended no later than Jan 21, 2020 | USPTO record |
| US 9,468,665 | Method of treating intraoccular tissue pathologies with nerve growth factor Formerly held Term ended Term ended Jan 21, 2020 · USPTO record | Term ended | Term ended Jan 21, 2020 | USPTO record |
| US 7,429,483 | Use of nerve growth factor for the storage, culture or treatment of cornea Formerly held Term ended Term ended Jan 13, 2020 · USPTO record | Term ended | Term ended Jan 13, 2020 | USPTO record |
| US 6,537,808 | Use of nerve growth factor for the storage, culture or treatment of cornea Formerly held Term ended Term ended Oct 25, 2019 · USPTO record | Term ended | Term ended Oct 25, 2019 | USPTO record |